Dr. Brian Lein Visits LRMC to Discuss DHA Transition
1 / 3 Show Caption + Hide Caption – Army Lt. Col. Kirk Giles, chief of Landstuhl Regional Medical Center (LRMC) European Medical Simulation Center, shows Defense Health Agency (DHA) Assistant Director Dr. Brian Lein simulation equipment during a tour of LRMC. Lein was visiting LRMC on March 3, to discuss changes under the DHA transition authorized by the 2017 National Defense Authorization Act. (Photo Credit: John Ciccarelli) VIEW ORIGINAL
Dr. Brian Lein Visits LRMC to Discuss DHA Transition
2 / 3 Show Caption + Hide Caption – Army Lt. Col. Kirk Giles, chief of Landstuhl Regional Medical Center (LRMC) European Medical Simulation Center, and Defense Health Agency (DHA) Assistant Director Dr. Brian Lein discuss the benefits of having simulation equipment at LRMC to support medical readiness. Lein was visiting LRMC on March 3, to discuss changes under the DHA transition authorized by the 2017 National Defense Authorization Act. (Photo Credit: John Ciccarelli) VIEW ORIGINAL
Dr. Brian Lein Visits LRMC to Discuss DHA Transition
3 / 3 Show Caption + Hide Caption – Dr. Brian Lein, assistant director for the Defense Health Agency (DHA), Healthcare Administration, hosts a professional development session at Landstuhl Regional Medical Center (LRMC) on March 3. He discussed the DHA transition, his leadership experience, and empowering teams to succeed. (Photo Credit: John Ciccarelli) VIEW ORIGINAL

Landstuhl Regional Medical Center (LRMC) recently welcomed Dr. Brian Lein, assistant director for Healthcare Administration at the Defense Health Agency (DHA), to discuss the transition for LRMC staff and operations from U.S. Army Medical Command to DHA, March 3.

During his visit, Lein, who works with the DHA director to standardize and unify health care across the Military Health System, toured emergency and critical care sections, and the LRMC European Medical Simulation Center.

“While change is inevitable, our mission, your mission here at LRMC is never going to change. It may take another name, people may change, but the mission will not,” he said during a townhall discussion with LRMC personnel.

Authorized by the 2017 National Defense Authorization Act, the transfer of U.S. Army medical treatment facilities to the DHA will preserve the capability of the DOD and the U.S. Army to conduct a full range of global military operations with a medically ready force.

“We have to take a hard look at where everyone is working and everything that they are doing to make sure we have the right skill set, with the right person in that job, to make sure we can respond to what the combatant commander needs to do,” said Army Col. Andrew L. Landers, LRMC Commander.

The Military Health System is transitioning the administration and management of all military and hospitals and clinics to DHA under a “market approach,” based on the six Enhanced Multi-Service Markets (eMSMs) already in place. Through this approach, DHA expects to increase collaboration across the Military Health System.

Lein also hosted a professional development session for LRMC leadership where he emphasized the importance of training and mentoring junior personnel.

“Your number one responsibility as a leader is to positively impact an individual in your command so they can succeed with performing their jobs and duties,” he said.